One-year real-life outcomes of lanadelumab therapy in Romanian patients with hereditary angioedema due to C1-inhibitor deficiency

One-year real-life outcomes of lanadelumab therapy in Romanian patients with hereditary angioedema due to C1-inhibitor deficiency

IntroductionIn the majority of patients with hereditary angioedema (HAE) due to C1-inhibitor deficiency (HAE-C1INH), effective long-term prophylactic (LTP) treatment can achieve complete disease control. Lanadelumab is one of the first-line option recommended for this purpose. Our study aimed to eva...

Full description

Saved in:
Bibliographic Details
Main Authors: Noémi Anna Bara, Valentin Nădășan, Diana Deleanu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Allergy
Subjects:
hereditary angioedema
C1-inhibitor
treatment
outcome
lanadelumab
Online Access:https://www.frontiersin.org/articles/10.3389/falgy.2025.1636425/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items